Clinical trial Recruiting at 1 site Interventional Ages 0 Minutes to 36 Months

Home monitoring for babies after heart surgery

Official title: Cardiopediatric Home Monitoring Tool

Run by Nantes University Hospital · NCT06741189 · Data updated 2026-11-12

This project tests a home monitoring system with telemedicine to help babies up to 3 years old who had congenital heart surgery to catch problems early and keep them safe at home.

More Congenital Heart Defect trials

Quick facts

Study typeInterventional
Ages0 Minutes to 36 Months
SexAll
Enrollment186 (estimated)
SponsorNantes University Hospital
Academic / other
Locations1 site (Nantes)
StatusRecruiting
StartedOctober 30, 2025
Main results expectedJuly 30, 2028
Study endsJuly 30, 2028
Registry record updatedJune 25, 2026
Trial IDNCT06741189 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Infants and young children (0-36 months) with congenital heart defects who had cardiac surgery at Nantes University Hospital and have caregiver consent and home connectivity.

Probably not a fit

Children without stable home connectivity or those with contraindicating clinical/family situations may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study aims to see whether a home monitoring program, using validated sensors and an alert system tailored to each care pathway, alongside standard postoperative care, can reduce morbidity and mortality in neonates and young children after cardiac surgery. It employs a protocolized medical response to alerts generated by the home tool. The population affected includes patients with congenital heart defects, focusing on high-risk postoperative periods such as interstage periods in staged palliation. The trial is conducted at Nantes University Hospital, leveraging the Exolis home platform for remote connectivity. Primary endpoints and statistical specifics are not provided in the available material.

Why it matters

Potential benefit: If successful, patients may experience earlier detection of complications and improved post-surgical outcomes through closer, at-home monitoring.

How similar studies have gone: Prior experiences with home telemedicine and sensor-based monitoring show potential, but this exact integrated approach remains relatively novel in this patient group.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged between 0 and 36 months inclusive
* With a congenital heart defect
* Underwent cardiac surgery at Nantes University Hospital
* Affiliated to a social security scheme
* Free, informed and written consent of the 2 holders of parental authority

Non Inclusion Criteria:

* Clinical or family situation contraindicating a return home
* Physical inability to connect to the Exolis platform at home
* Insufficient understanding on the part of those with parental authority
* Extracardiac co-morbidities responsible for organ failure requiring repeated
* Hospitalisation for non-cardiovascular reasons (e.g. severe renal failure, neurological neurological deficit, complex immune deficiency, etc).
* Patient and/or parents under legal protection

Where it's running

  • CHU de Nantes
    Nantes, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.